New Delhi, 5/3: An expert panel of India’s central drug authority has recommended the permission for conducting phase-3 clinical trial of single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday.
The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The DCGI had on February 4 granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory provisions.
Hyderabad-based Dr. Reddy’s Laboratories had presented its proposal to DCGI for conducting the phase-3 trial of Sputnik Light vaccine as booster dose.